LEWISVILLE, Texas, Dec. 17, 2020 /PRNewswire-PRWeb/ -- BayMark Health Services recently announced their partnership with Recovery Pathways, an office-based opioid treatment (OBOT) provider with three locations in Western Pennsylvania. The programs, two of which are located in Washington, PA and the third in Monroeville, PA, offer medication-assisted treatment (MAT) for opioid addiction using buprenorphine-based medications in an outpatient, physician's office setting. Buprenorphine-based medications include Suboxone®, Subutex® and Zubsolv®. Recovery Pathways three convenient locations provide comprehensive treatment to patients with Opioid Use Disorder (OUD) from western Pennsylvania, Ohio and West Virginia.
BayMark now operates or collaborates with eight outpatient, office-based opioid treatment (OBOT) locations in Pennsylvania including Family Recovery Solutions in Central PA, as well as three MedMark Treatment Centers Opioid Treatment Programs offering both methadone and buprenorphine-based products, located east of Pittsburgh. All BayMark-affiliated facilities share a common goal, to improve access to comprehensive and compassionate treatment for individuals who wish to overcome opioid misuse. The outpatient, flexible services provided by OBOT's allow patients to maintain their commitments and keep living their lives during treatment.
Mike Saul, BayMark Division President, shared, "As we face an unprecedented health crisis across this country, it is easy to forget that the opioid epidemic continues to take more than 130 lives per day. Now, more than ever, people need safe, effective treatment options for substance use disorders. BayMark is proud to continue our work providing such treatment to those who need it, despite the current challenges, and are even more proud to do so through partnerships with providers such as Recovery Pathways."
For more information, to make an appointment or refer a patient, contact us at 412.502.5124 or visit RecoveryPathways.net.
About BayMark Health Services:
BayMark Health Services provides medication-assisted treatment to 62,000+ patients in recovery from substance use disorder across the United States and Canada. Our outpatient programs deliver medically-supervised treatment, in a variety of modalities and settings, to meet the diverse needs of our patients who struggle with the use of opioids, alcohol and other prescription and illicit substances.
The BayMark continuum of patient-focused services includes: highly structured opioid treatment programs utilizing methadone or buprenorphine and outpatient buprenorphine treatment programs, both of which incorporate counseling as part of an individualized treatment plan for opioid use disorder. Additionally, ambulatory withdrawal management services with naltrexone therapy, and inpatient detoxification services are offered for a variety of substance use disorders.
Robin Johnson, BayMark Health Services, 214.379.3300, [email protected]
SOURCE BayMark Health Services